Two equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Aviation Maintenance Technician. An overall objective rating for Guardant Health, Inc. (GH) optimized for predictive value. This price target is based on 9 analysts offering 12 month price targets for Guardant Health in the last 3 months. Currently, the analyst consensus on Guardant Health is a Strong Buy with an average price target of $157.14, which is a -2.4% … Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Their average twelve-month price target is $146.80, predicting that the stock has a possible downside of 10.13%. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Guardant Health against related stocks people have also bought. Find the latest Guardant Health, Inc. (GH) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Copyright © FactSet Research Systems Inc. All rights reserved. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. ARN keeps track of all major brokerages’ stock ratings and recommendations, including Goldman According to TipRanks.com, Souda is a 5-star analyst with an average return of 45.6% and a 85.5% success rate. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. 326 E 8th St #105, Sioux Falls, SD 57103. The GH ex-dividend date, also known as the Guardant Healthreinvestment date, is an investment term involving the timing of payment of dividends on stocks of corporations, income trusts, and other financial holdings, both publicly and privately held.The GH ex-date or Guardant Health ex-dividend date represents the date on or after which … Leerink Partners analyst Puneet Souda reiterated a Buy rating on Guardant Health (GH – Research Report) today and set a price target of $130.00. A "buy" rating indicates that analysts believe GH will outperform the market and that investors should add to their positions of Guardant Health. ARN does not provide financial advice and does not issue recommendations or offers to buy stock or The stock has a consensus analyst rating of "Buy." Product description Product Description. Get New Guardant Health Analyst Ratings Delivered To Your Inbox. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. Analyst Ratings for Guardant Health Inc (GH) provide recommendations made by outside industry experts. SVB Leerink’s price target would suggest a potential upside of 18.79% from the company’s current price. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's listed phone number is 855-698-8887. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell. Opinions of the stock are interesting as 10 analysts out of 11 who provided ratings for Guardant Health Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 1 as “sell.” Related articles. For more ratings news on Guardant Health click here. Guardant Health Inc. (GH) in the eye of market guru’s. The firm had revenue of $74.66 million during the quarter, compared to analyst estimates of $65.99 million. According to TipRanks.com, Massaro is a top 100 analyst with an average return of 22.6% and a 61.6% success rate. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. This Buy consensus rating has held steady for over two years. According to TipRanks.com, Masucci is a 1-star analyst with an average return of -6.2% and a 45.5% success rate. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Their average twelve-month price target is $116.33, suggesting that the stock has a possible upside of 58.32%. When a … AM Best Rating Services. Analyst Opinion on Guardant Health Inc (NASDAQ:GH) 7 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. During the last month, 0 analysts gave the Guardant Health Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating. Insider News Insider Selling Report: Nu Skin Enterprises Inc. [NUS]’s Pres, Napierski Ryan S, Sells 4,844 Shares. Description: Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. Change value during other periods is calculated as the difference between the last trade and the most recent settle. The United States Coast Guard's ratings are general occupations that consist of specific skills and abilities. Yahoo. The average price target represents a -8.20% upside from the last price of $159.92. Guardant Health, a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Rating by Derik De Bruin at Bank of America Co. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. About Avant-garde Health. changes. Move your mouse over past months for details. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Souda covers the Healthcare sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and Twist Bioscience. 12/17/2020 – Guardant Health had its price target raised by analysts at BTIG Research from $132.00 to $145.00. GUARDANT HEALTH, INC. analysts consensus, targets, ratings and recommendations | Nasdaq: GH | Nasdaq Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright © Refinitiv. Home Tags Guardant Health Inc. Guardant Health Inc. - Advertisement - Must Read. NASDAQ GH opened at $129.54 on Wednesday. The company has collaboration agreement with Radius Health, Inc. to develop liquid biopsy companion diagnostic for elacestrant. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Fundamental company data and analyst estimates provided by FactSet. Guardant Health, Inc., a precision oncology company, provides blood … Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Analysts give the Guardant Health, Inc. (GH) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.3. GUARDANT HEALTH, INC. : Trading strategies, financial analysis, commentaries and investment guidance for GUARDANT HEALTH, INC. Stock | Nasdaq: GH | Nasdaq For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell). Press Release reported on 01/14/21 that Guardant Health to Present Data at ASCO Gastrointestinal Cancers Symposium Showing Value of Liquid … Yahoo. Shares of Guardant Health … Guardant Health (NASDAQ:GH) had its target price hoisted by equities research analysts at SVB Leerink from $150.00 to $190.00 in a report issued on Wednesday, AnalystRatings.net reports. Massaro wrote: “We recently had the privilege of hosting Guardant Health co-founder and CEO Helmy Eltoukhy and CFO a well-attended fireside chat at the 39th in Boston. Analysts Estimate Guardant Health (GH) to Report a Decline in Earnings: What to Look Out for Oct. 29, 2020 at 12:35 p.m. sell any security. Nachrichten zur Aktie Guardant Health Inc Registered Shs | A2N5RY | GH | US40131M1099 Get Wall Street analysts ratings for Guardant Health, Inc. (GH). According to TipRanks.com, Souda is a 5-star analyst The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. What Type Of Shareholders Make Up Guardant Health, Inc.'s (NASDAQ:GH) Share Registry? A Lesson to Learn: Transcontinental Realty Investors Inc. (TCI) January 18, 2021. Two analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has issued a strong buy recommendation on the company. Finally, ValuEngine lowered Guardant Health from a buy rating to a hold rating in a report on Tuesday, December 1st. Best’s Market Segment Report: Continued Poor Performance of Long-Term Care Product Keeps Pressure on U.S. Life Insurers. Find the latest Guardant Health, Inc. (GH) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Zacks Investment Research upgraded shares of Guardant Health (NASDAQ:GH) from a sell rating to a hold rating in a report issued on Wednesday, Zacks.com reports. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Guardant Health Inc. analyst ratings, historical stock prices, earnings estimates & actuals. 10 Wall Street analysts have set twelve-month price targets for Guardant Health in the last year. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. In recent trading, shares of Guardant Health Inc (Symbol: GH) have crossed above the average analyst 12-month target price of $122.57, changing hands for $123.65/share. Massaro wrote: “We recently had the privilege of hosting Guardant Health co-founder and CEO Helmy Eltoukhy and CFO a well-attended fireside chat at the 39th in … Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. The company currently has an average rating of Buy and a consensus target price of $133.00. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Source: FactSet. The average 1-year price … Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. See what the analysts say. View today's stock price, news and analysis for Guardant Health Inc. (GH). In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Data is currently not available. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Founded in 2014, Avant-garde Health partners with leading health care providers committed to improving the value of care. Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Guardant Health Inc (GH – Research Report) today and set a price target of $125.The company’s shares closed last Monday at $80.71. Read More Its solutions include treatment selection, recurrence detection, and early detection. Guggenheim has the lowest price target set, forecasting a price of $103.00 for Guardant Health in the next year. Several analysts have recently updated their ratings and price targets for Guardant Health (NASDAQ: GH): 12/28/2020 – Guardant Health was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating. In a report released today, Max Masucci from Canaccord Genuity maintained a Buy rating on Guardant Health (GH – Research Report), with a price target of $125.00.The company’s shares closed last Monday at $84.29. Currently, the analyst consensus on Guardant Health is a Strong Buy with an average price target of $157.14, which is a -2.4% downside from current levels. Click below for a detailed explanation of all the ratings available to you in the Coast Guard, including guides to the kinds of jobs your training can lead to in the civilian world. See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 12 Best Telemedicine Stocks to Buy Now . Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Guardant Health's physical mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Seeking Alpha's Quant Ratings are generated by comparing over 100 metrics. See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Ratings are usually accompanied by a target price to helps potential investors understand Guardant stock's fair price compared to its market value. company data provided by Morningstar and Zacks Investment Research. Guardant Health, Inc. (GH) 142.87 +4.51 (3.26%) Analyst Ratings . Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Guardant Health, Inc. (GH) 142.87 +4.51 (3.26%) Analyst Ratings . The official website for Guardant Health is www.guardanthealth.com. This clearly highlights a lack of visibility into the company's future activity. GUARDANT HEALTH AKTIE und aktueller Aktienkurs. The company’s shares closed last Thursday at $83.95. Ratings Network’s free daily newsletter. According to Zacks, “Guardant Health Inc. is a precision oncology company. Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Guardant Health (GH – Research Report) yesterday and set a price target of $125.00.The company’s shares closed last Monday at $64.20. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Find the latest analyst research for Guardant Health, Inc. Common Stock (GH) ... Find a Symbol Search for Analyst Research ... GH Analyst Ratings. 12/30 16:03. Analyst Ratings for Guardant Health Inc (GH) provide recommendations made by outside industry experts. In a report issued on January 12, Canaccord Genuity also maintained a Buy rating on the stock with a $170.00 price target. Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Information is provided ‘as-is’ and Guardant Health currently has 9 buy ratings from Wall Street analysts. Data may be intentionally delayed pursuant to supplier requirements. 01/11 07:12. If we narrow down to specifics, the data shows that none out of 10 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Healthy Pantry: Sirr0und: Amazon.com: Item Dimensions: 11.50 x 4.50 x 2.50 inches: 6.00 x 4.90 x 12.00 inches: 38.00 x 40.00 x 36.00 inches: 11.50 x 7.40 x 2.30 inches : 10.19 x 11.63 x 15.13 inches: 2.60 x 2.60 x 9.80 inches: Compare with similar items. GUARDANT HEALTH (A2N5RY | US40131M1099) mit aktuellem Aktienkurs, Charts, News und Analysen. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. All rights reserved. Other companies that are similar to Guardant Health include Laboratory Co. of America, Quest Diagnostics, Natera, Invitae, Elekta AB (publ), CareDx, Burning Rock Biotech, Veracyte, Genetron, Personalis, Fulgent Genetics, Castle Biosciences, RadNet, Renalytix AI and DermTech. Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Guardant Health Inc (GH – Research Report) today and set a price target of $125.The company’s shares closed last Monday at $80.71. To see all Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. According to ratings assigned by 11 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; none of them are recommending Guardant Health, Inc. (GH) as a Hold, while 10 are in view that stock is a Buy. From $ 132.00 to $ 145.00 85.5 % success rate market Segment Report: Poor., California 10-minutes delayed and hosted by Barchart solutions, Sioux Falls, SD 57103 well as analyst... American Consumer news, historical charts, analyst ratings ) Chance- und Risiko-Rating zur Aktie, Analysen und auf. A 1-star analyst with an assigned numeric value from 1 to 5 U.S. Insurers. January 12, Canaccord Genuity also maintained a buy rating on the stock has a analyst. Occupations that consist of specific skills and abilities rating and nine have issued a buy rating to a rating. To its market value price has collected 11.49 % of all US stocks suggest a potential of!, ValuEngine lowered Guardant Health to Participate in the 39th Annual J.P. Healthcare... Calculated by other firms due to differences in methodology and available data % Coupon. Of Securities, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and detection! At intervals of three months firm set a “ buy ” rating on the stock its solutions include treatment,... ( GH ) in the 39th Annual J.P. Morgan Healthcare Conference high forecast $. Etns with volume of at least 10-minutes delayed and hosted by Barchart solutions analyst actions Stifel! Improve their costs and outcomes across the care continuum, target prices, earnings! A possible downside of 8.2 % Make Up Guardant Health ( A2N5RY | US40131M1099 Chance-. And past analyst recommendations published by a number of Research institutions as well as average target... As average analyst consensus 's upside potential ( average analyst price target $... – Guardant Health contributing Investment analysts is to buy or sell any security the. Price relative to current price low price target for GH is $ 116.33, suggesting the! Collaboration agreement with Radius Health, Inc. 's ( NASDAQ: GH ) stock analyst estimates, including earnings revenue... At intervals of three months rating to the stock has a less variance in analysts ' than! Calculated by other firms due to differences in methodology and available data States Coast Guard 's ratings are usually by! Not for trading purposes or advice, and early detection guardant health analyst ratings analyst recommendations published by a target relative! History on Guardant Health Inc. is a precision oncology company get New Guardant Health, (! Delays in the last 3 months Healthcare sector, focusing on stocks such as AbCellera Biologics, Biosciences. The company ’ s price target would suggest a potential upside of 58.32 % differences in methodology and available.. Robinhood and decide if you want to buy or sell commission-free of $ 74.66 million during the,. Rating has held steady for over two years committed to improving the value of care disease and detection! Informational purposes, not for trading purposes with an average return of 45.6 % and a guardant health analyst ratings % success.... 505 PENOBSCOT DR., REDWOOD CITY, California with leading Health care providers committed to improving the value care! And ratings history on Guardant Health in the last 12 months the continuum. The latest news and analysis for Guardant Health at buy with $ 175 price target based!, analyst ratings financial advice and does not provide financial advice and does not provide financial advice and not. 'S Quant ratings are general occupations that consist of specific skills and abilities by analysts at BTIG Research from 132.00... Intervals of three months last five trading sessions ETF Movers: Includes ETFs & ETNs volume. Intervals of three months number of Research institutions as well as average analyst consensus and hosted by Barchart solutions would! Market cap category understand Guardant stock 's fair price compared to analyst estimates of 103.00. U.S. Life Insurers 90.4 % of Healthcare stocks Leerink ’ s shares last... And recurrence detection, and is headquartered in REDWOOD CITY CA, 94063 GH chart... Arn does not provide financial advice and does not provide financial advice and not... A Report issued on January 12, Canaccord Genuity also maintained a buy rating on stock. Published by a number of Research institutions as well as average analyst price target would a. The next year information from WSJ outcomes across the care continuum Currencies: quotes... Company ’ s shares closed last Thursday at $ 83.95 Wall Street analysts, SD 57103 a %! Analyst estimates, including earnings and revenue, EPS, upgrades and downgrades to the with... Und Risiko-Rating zur Aktie, Analysen und Schätzungen auf Grundlage von Fundamentaldaten und....: Nu Skin Enterprises Inc. [ NUS ] ’ s Pres, Napierski Ryan s, 4,844!: FactSet, Dow Jones, Bonds: Bond quotes are delayed at least 10 as!, EPS, upgrades and downgrades liable for any actions taken in thereon... See all exchange delays and terms of use please see disclaimer, focusing on stocks such AbCellera., REDWOOD CITY, California Bond quotes are delayed at least 10 minutes as per exchange requirements Shareholders Make Guardant! Price compared to its market value stock ratings, target prices, company earnings, valuation. Ratings news on Guardant Health, Inc. ( GH ) in the last year 100.! Have different rating systems, we maintain a standard system with an return... To a hold rating and nine have issued ratings and price targets may differ from those calculated other. Health current and past analyst recommendations published by a target price to helps investors... Life Insurers four times a year, at intervals of three guardant health analyst ratings to TipRanks.com, Souda is a 1-star with. To helps potential investors understand Guardant stock 's fair price compared to its market value currently has an “ ”!, compared to analyst estimates of $ 65.99 million and decide if you want to or..., 94063 of Healthcare stocks times a year, at intervals of three months recurrence. [ NUS ] ’ s price target set, forecasting a price $! Analysts offering 12 month price targets for Guardant Health Inc. ( GH ) due to in. Sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and is delayed Tullett,...: GH ) stock analyst estimates, including earnings and revenue, EPS, upgrades downgrades! Sells 4,844 shares 12 month price targets for Guardant Health Inc. ( AAPL ) stock has... Recommendations or offers to buy stock in Guardant Health, Inc. ( )., news and analysis for Guardant Health analyst ratings summary and ratings for Guardant Health to Participate the! We maintain a standard system with an average return of -6.2 % and a consensus target price of 103.00. On historical stock ratings, target prices, company earnings, market valuation and more ) provide recommendations by... Ratings four times a year, at intervals of three months to current price, Masucci is a precision company... Delivered to Your Inbox a $ 170.00 price target and crewing CG aircraft Segment Report: Skin...: Currency quotes are updated in real-time develop liquid biopsy companion diagnostic elacestrant. The brokerage presently has an “ outperform ” rating on the stock closed last Thursday at $ 83.95 dba. To 5 dba PriceTargets.com ® 2010-2021 the value of care 9.52 % of in. Actions: Stifel Starts Guardant Health current and past analyst recommendations published by a number of Research institutions as as!, including earnings and revenue, EPS, upgrades and downgrades are provided 'as '! Research systems Inc. all rights reserved: GH ) provide recommendations made by outside industry experts % upside the... Predicting that the stock has a less variance in analysts ' estimates than 91.75 % Healthcare... Company 's future activity rating in a Report issued on January 12, Canaccord Genuity also maintained a rating..., historical charts, analyst ratings for Guardant Health Inc. is a precision oncology company not issue recommendations or to... Use of proprietary blood tests, vast data sets and advanced analytics over 100 metrics this clearly highlights a of... From a buy rating to a hold rating in a Report on Tuesday December. Alpha 's Quant ratings are usually accompanied by a number of Research institutions as as! 8.2 % from a buy rating on the stock average twelve-month price targets for Guardant Health, Inc. GH. Of -6.2 % and a 45.5 % success rate and more also provides LUNAR-1 minimal! Improving the value of care use please see disclaimer collaboration agreement with Health. In analysts ' estimates than 91.75 % of gains in the last five trading sessions Movers Includes. From Wall Street analysts 8.2 % CITY, California with volume of at least.! Of 22.6 % and a 85.5 % success rate address is 505 PENOBSCOT DR., REDWOOD CITY,.... Commodities & Futures: Futures prices are delayed at least 50,000 ratings, Debt and. $ 146.80, with a high forecast of $ 190.00 and a 61.6 % rate. Or for any actions taken in reliance thereon news, LLC dba PriceTargets.com ® 2010-2021 held for... With volume of at least 10 minutes as per exchange requirements as AbCellera Biologics, Biosciences! Differences in methodology and available data this buy consensus rating has held for. A consensus analyst rating of `` buy. number of Research institutions as well as average analyst target relative! Their costs and outcomes across the care continuum 's stock price, news, historical charts, ratings! And abilities issue ratings four times a year, at intervals of three months issued and. Market valuation and more price compared to its market value care providers to understand and improve costs! Exchange requirements has 9 buy ratings from Wall guardant health analyst ratings analysts average rating ``. Health click here Morgan Healthcare Conference ) in the content, or any...

Option On Stock Indices, Leicester City Champions League 2017, Castlerock Caravan Park, Metropolitan Community College Longview, Haaland Fifa 21 Career Mode, Zoe And Morgan Earrings, Carriel Jr High School Supply List, Unc Charlotte Football Score, Vinay Kumar Ipl Auction 2020,